MEI Pharma (MEIP) Granted FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib
Tweet Send to a Friend
MEI Pharma, Inc. (NASDAQ: MEIP) today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
